Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclizumab, MMF, and Sirolimus in Heart Transplant
NCT02554955Phase 4Completed
- Sponsor
- Roche
- Start
- Feb 2004
- Primary completion
- Dec 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of daclizumab in heart transplant rejection, sponsored by Roche. Started Feb 2004; status: completed.
02
Drugs
daclizumab
03
Conditions
heart transplant rejection
Beyond the preview
Go deeper on NCT02554955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02554955.